Vaccine development continues to a be a source for good news in the fight against COVID-19. AstraZeneca announced its vaccine candidate entered the final stage of testing in the US, while Moderna, Pfizer and BioNTech have vaccine candidates entering phase-three testing. Economic fundamentals point to continued improvement, with manufacturing, consumer sentiment, and unemployment claims all improving in August. To offer some overall perspective on the market and what may come next, attached is the most recent edition of Market Matters. As always, we continue to closely monitor market conditions, and we’re here to assist you however we can. If you have any questions or concerns, please don’t hesitate to reach out. |
